Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

NYSE:XPOF - New York Stock Exchange, Inc. - US98422X1019 - Common Stock - Currency: USD

8.27  +0.46 (+5.89%)

After market: 8.27 0 (0%)

Fundamental Rating

3

Overall XPOF gets a fundamental rating of 3 out of 10. We evaluated XPOF against 136 industry peers in the Hotels, Restaurants & Leisure industry. While XPOF is still in line with the averages on profitability rating, there are concerns on its financial health. XPOF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

XPOF had negative earnings in the past year.
XPOF had a positive operating cash flow in the past year.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -18.04%, XPOF is doing worse than 91.18% of the companies in the same industry.
The Return On Invested Capital of XPOF (18.41%) is better than 89.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for XPOF is significantly below the industry average of 15.76%.
The 3 year average ROIC (10.38%) for XPOF is below the current ROIC(18.41%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -18.04%
ROE N/A
ROIC 18.41%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a better Operating Margin (21.49%) than 81.62% of its industry peers.
Looking at the Gross Margin, with a value of 74.66%, XPOF belongs to the top of the industry, outperforming 91.91% of the companies in the same industry.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 21.49%
PM (TTM) N/A
GM 74.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), XPOF is creating some value.
The number of shares outstanding for XPOF has been increased compared to 1 year ago.
The number of shares outstanding for XPOF has been increased compared to 5 years ago.
XPOF has a worse debt/assets ratio than last year.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.70, we must say that XPOF is in the distress zone and has some risk of bankruptcy.
XPOF has a worse Altman-Z score (-0.70) than 90.44% of its industry peers.
XPOF has a debt to FCF ratio of 68.07. This is a negative value and a sign of low solvency as XPOF would need 68.07 years to pay back of all of its debts.
XPOF has a worse Debt to FCF ratio (68.07) than 63.97% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 68.07
Altman-Z -0.7
ROIC/WACC1.71
WACC10.74%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 0.78 indicates that XPOF may have some problems paying its short term obligations.
The Current ratio of XPOF (0.78) is comparable to the rest of the industry.
A Quick Ratio of 0.69 indicates that XPOF may have some problems paying its short term obligations.
XPOF has a Quick ratio (0.69) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.69
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

XPOF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.67%.
Looking at the last year, XPOF shows a small growth in Revenue. The Revenue has grown by 0.53% in the last year.
The Revenue has been growing by 19.93% on average over the past years. This is quite good.
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-7.73%

3.2 Future

XPOF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 198.06% yearly.
XPOF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.47% yearly.
EPS Next Y1071.55%
EPS Next 2Y300.79%
EPS Next 3Y198.06%
EPS Next 5YN/A
Revenue Next Year0.55%
Revenue Next 2Y3.67%
Revenue Next 3Y6.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

XPOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.51, the valuation of XPOF can be described as very reasonable.
XPOF's Price/Forward Earnings ratio is rather cheap when compared to the industry. XPOF is cheaper than 92.65% of the companies in the same industry.
XPOF's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE N/A
Fwd PE 8.51
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XPOF is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of XPOF is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 77.87
EV/EBITDA 8.04
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XPOF's earnings are expected to grow with 198.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y300.79%
EPS Next 3Y198.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPONENTIAL FITNESS INC-A

NYSE:XPOF (4/28/2025, 8:04:00 PM)

After market: 8.27 0 (0%)

8.27

+0.46 (+5.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners80.89%
Inst Owner Change0.25%
Ins Owners4.3%
Ins Owner Change-1.3%
Market Cap400.93M
Analysts78.75
Price Target14.59 (76.42%)
Short Float %13.09%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-7.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.29%
Min EPS beat(2)-147.92%
Max EPS beat(2)-114.66%
EPS beat(4)0
Avg EPS beat(4)-100.65%
Min EPS beat(4)-147.92%
Max EPS beat(4)-27.04%
EPS beat(8)0
Avg EPS beat(8)-80.62%
EPS beat(12)0
Avg EPS beat(12)-185.3%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.89%
Min Revenue beat(2)0.58%
Max Revenue beat(2)3.21%
Revenue beat(4)2
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)2.18%
Revenue beat(12)10
Avg Revenue beat(12)5.07%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25.17%
EPS NQ rev (1m)-35.47%
EPS NQ rev (3m)-53.02%
EPS NY rev (1m)-13.8%
EPS NY rev (3m)-38.05%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-6.45%
Revenue NY rev (1m)-5.92%
Revenue NY rev (3m)-6.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.51
P/S 1.25
P/FCF 77.87
P/OCF 34.34
P/B N/A
P/tB N/A
EV/EBITDA 8.04
EPS(TTM)-0.1
EYN/A
EPS(NY)0.97
Fwd EY11.75%
FCF(TTM)0.11
FCFY1.28%
OCF(TTM)0.24
OCFY2.91%
SpS6.61
BVpS-2.06
TBVpS-6.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.04%
ROE N/A
ROCE 23.3%
ROIC 18.41%
ROICexc 20.7%
ROICexgc 204.57%
OM 21.49%
PM (TTM) N/A
GM 74.66%
FCFM 1.61%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 68.07
Debt/EBITDA 3.95
Cap/Depr 36.85%
Cap/Sales 2.04%
Interest Coverage 1.67
Cash Conversion 13.49%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.69
Altman-Z -0.7
F-Score3
WACC10.74%
ROIC/WACC1.71
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-337.5%
EPS Next Y1071.55%
EPS Next 2Y300.79%
EPS Next 3Y198.06%
EPS Next 5YN/A
Revenue 1Y (TTM)0.53%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-7.73%
Revenue Next Year0.55%
Revenue Next 2Y3.67%
Revenue Next 3Y6.47%
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year547.17%
EBIT Next 3Y104.38%
EBIT Next 5YN/A
FCF growth 1Y-77.94%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-64.3%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%